Table 4.
Predictors of major adverse clinical event.
| Variable | Hazard Ratio | 95% Confidential Interval | p-Value |
|---|---|---|---|
| Univariate analysis | |||
| Age (year) | 1.029 | 1.015–1.044 | <0.001 |
| Male sex | 0.988 | 0.692–1.412 | 0.949 |
| BMI (kg/m2) | 0.990 | 0.938–1.046 | 0.727 |
| Killip class III/IV | 1.390 | 0.709–2.725 | 0.338 |
| SBP (mmHg) | 1.005 | 0.999–1.010 | 0.095 |
| DBP (mmHg) | 1.001 | 0.998–1.007 | 0.627 |
| HR (/min) | 1.008 | 1.000–1.015 | 0.052 |
| Cardiac rehabilitation | |||
| No-CR group | Reference | ||
| Insufficient-CR group | 0.693 | 0.477–1.007 | 0.055 |
| CR group | 0.606 | 0.367–1.000 | 0.049 |
| STEMI | 0.790 | 0.575–1.084 | 0.145 |
| Hypertension | 1.590 | 1.158–2.184 | 0.004 |
| Diabetes | 1.675 | 1.215–2.309 | 0.002 |
| Smoking | 0.819 | 0.566–1.185 | 0.290 |
| Creatinine | 1.032 | 0.934–1.141 | 0.507 |
| CK-MB | 1.000 | 1.000–1.000 | 0.723 |
| Troponin-I | 0.999 | 0.997–1.002 | 0.620 |
| Baseline LVESV (mL) | 1.000 | 0.993–1.006 | 0.884 |
| Baseline LVEF (%) | 0.995 | 0.980–1.010 | 0.514 |
| Baseline LAVI (mL/m2) | 1.013 | 1.004–1.022 | 0.004 |
| Baseline E/e’ ratio | 1.047 | 1.025–1.069 | <0.001 |
| Baseline TR Vmax (m/s) | 1.546 | 1.017–2.349 | 0.041 |
| No. of baseline diastolic parameters | 1.210 | 1.060–1.382 | 0.005 |
| Follow-up LVESV (mL) | 1.008 | 1.002–1.014 | 0.011 |
| Follow-up LVEF (%) | 0.988 | 0.975–1.001 | 0.066 |
| Follow-up LAVI (mL/m2) | 1.020 | 1.012–1.027 | <0.001 |
| Follow-up E/e’ ratio | 1.032 | 1.014–1.051 | <0.001 |
| Follow-up TR Vmax (m/s) | 2.216 | 1.568–3.132 | <0.001 |
| No of follow-up diastolic parameters | 1.356 | 1.198–1.536 | <0.001 |
| Multivariate analysis | |||
| Age (year) | 1.035 | 1.018–1.052 | <0.001 |
| SBP (mmHg) | 1.005 | 0.999–1.011 | 0.100 |
| HR (/min) | 1.002 | 0.995–1.010 | 0.555 |
| Hypertension | 1.228 | 0.869–1.736 | 0.245 |
| Diabetes | 1.627 | 1.158–2.286 | 0.005 |
| Follow-up LVESV (mL) | 0.999 | 0.992–1.007 | 0.883 |
| Follow-up LVEF (%) | 0.995 | 0.984–1.006 | 0.374 |
| Cardiac rehabilitation | |||
| No-CR group | Reference | ||
| Insufficient-CR group | 0.702 | 0.478–1.031 | 0.071 |
| CR group | 0.738 | 0.440–1.237 | 0.249 |
| No of follow-up diastolic parameters | 1.255 | 1.076–1.465 | 0.004 |
BMI, body mass index; CK-MB, creatinine kinase MB fraction; DBP, diastolic blood pressure; HR, heart rate; LAVI, left atrial volume index; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; SBP, systolic blood pressure; TR Vmax, maximal velocity of tricuspid regurgitation.